Transplantation across previously incompatible immunological barriers.
This article reviews recent advances, which allow the transplantation across or around previously incompatible immunological barriers such as a positive crossmatch or ABO blood group incompatibility.
Magee
Colm C
CC
Renal Division, Brigham and Women's Hospital, Boston, MA, USA. cmagee@partners.org
D000017:ABO Blood-Group System / Q000276:immunology; D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D058846:Antibodies, Monoclonal, Murine-Derived; D002985:Clinical Protocols; D003888:Desensitization, Immunologic; D006084:Graft Rejection / Q000276:immunology / Q000517:prevention & control; D006680:HLA Antigens / Q000276:immunology; D006650:Histocompatibility Testing; D006801:Humans; D016756:Immunoglobulins, Intravenous / Q000627:therapeutic use; D007165:Immunosuppression Therapy; D016030:Kidney Transplantation / Q000276:immunology; D019520:Living Donors; D010956:Plasmapheresis; D000069283:Rituximab; D013601:T-Lymphocytes / Q000276:immunology; D014181:Transplantation Immunology
D000017:ABO Blood-Group System; D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; D006680:HLA Antigens; D016756:Immunoglobulins, Intravenous; D000069283:Rituximab